Lensar (LNSR) Loans and Notes Receivables (2019 - 2026)
Lensar (LNSR) reported Loans and Notes Receivables of $287000.0 for Q1 2026, down 19.61% year-over-year from $357000.0 in Q1 2025, and down 2.71% on a QoQ basis from $295000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Loans and Notes Receivables data on file, last reported at $287000.0 in Q1 2026.
- Quarterly Loans and Notes Receivables fell 19.61% year-over-year to $287000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $287000.0 (down 19.61% YoY) and the FY2025 annual result came in at $295000.0, down 25.32% from the prior year.
- Loans and Notes Receivables retreated to $287000.0 in Q1 2026 per LNSR's latest filing, from $295000.0 in the prior quarter.
- Across five years, Loans and Notes Receivables topped out at $595000.0 in Q2 2023 and bottomed at $126000.0 in Q3 2022.
- The 5-year median for Loans and Notes Receivables is $295000.0 (2025), against an average of $296647.1.
- The widest annual swing landed in 2022, when Loans and Notes Receivables tumbled 65.85%; it then surged 262.8% in 2023.
- Tracing LNSR's Loans and Notes Receivables over 5 years: stood at $200000.0 in 2022, then jumped by 61.5% to $323000.0 in 2023, then increased by 22.29% to $395000.0 in 2024, then slipped by 25.32% to $295000.0 in 2025, then slipped by 2.71% to $287000.0 in 2026.
- Per Business Quant, the three latest LNSR Loans and Notes Receivables figures stand at $287000.0 (Q1 2026), $295000.0 (Q4 2025), and $287000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans & Notes Receiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 287,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 287,000.00 |
| Dec 31, 2025 | 295,000.00 |
| Sep 30, 2025 | 287,000.00 |
| Jun 30, 2025 | 335,000.00 |
| Mar 31, 2025 | 357,000.00 |
| Dec 31, 2024 | 395,000.00 |
| Sep 30, 2024 | 352,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 323,000.00 |
| Sep 30, 2023 | 264,000.00 |
| Jun 30, 2023 | 595,000.00 |
| Mar 31, 2023 | 203,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 126,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Dec 31, 2021 | 350,000.00 |
| Sep 30, 2021 | 369,000.00 |
| Jun 30, 2021 | 436,000.00 |
| Mar 31, 2021 | 427,000.00 |
| Dec 31, 2020 | 444,000.00 |
| Sep 30, 2020 | 451,000.00 |
| Dec 31, 2019 | 502,000.00 |